Pediatric Patient-Reported Outcome Instruments for Research to Support Medical Product Labeling: Report of the ISPOR Good Research Practices for the Assessment of Patient-Reported Outcomes in Children and Adolescents Task Force
The citation for this report is:
Matza LS, Patrick D, Riley AW et al. Pediatric patient-reported outcome instruments for research to support medical product labeling: Report of the ISPOR PRO good research practices for the assessment of children and adolescents task force. Value Health 2013:16;461-79.
Translations: » Bulgarian
Louis Matza, PhD, Task Force Chair and Research Scientist, Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD, USA
John J. Alexander, MD, MPH, Medical Team Leader, Division of Anti-Infective and Ophthalmology Products, FDA, Silver Spring, MD, USA
Monika Bullinger, MD, PhD, Professor & Vice Chief, Institute and Polyclinic for Medical Psychology, University Clinics-Eppendorf, University of Hamburg, Hamburg, Germany
Donald L. Patrick, PhD, MSPH, Professor, Department of Health Services, University of Washington, Seattle, WA, USA
Andreas M. Pleil, PhD, Senior Director / Lead, Ophthalmology and Endocrinology Outcomes Research, Clinical Development & Medical Affairs, Specialty Care Business Unit, Pfizer Global Pharmaceuticals, Pfizer, Inc., San Diego, CA, USA
Luis Rajmil, MD, PhD, MPH, Senior Researcher, Catalan Agency for Health Technology Assessment & Research (CAHTA), & Collaborator, Health Services Research Unit, Municipal Institute of Medical Research (IMIM-Hospital del Mar), Barcelona, Spain
Anne W. Riley, PhD, MS, Professor, Department of Population, Family & Reproductive Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA
The task force sent out drafts for review twice during the development process. The task force received written comments from more than 40 ISPOR member reviewers. All comments were read and addressed as appropriate.